Typical Antipsychotics - Classic Dopamine Blockers
- Primary Mechanism: Block dopamine Dā receptors in the central nervous system.
- Effective against positive symptoms (hallucinations, delusions).
- Potency is directly related to Dā receptor affinity.
- Adverse Effects by Pathway:
- Nigrostriatal Blockade: Causes Extrapyramidal Symptoms (EPS) like dystonia, akathisia, and parkinsonism.
- Tuberoinfundibular Blockade: Disinhibits prolactin release ā ā Prolactin levels, causing gynecomastia and galactorrhea.

ā High-potency agents (e.g., Haloperidol) carry a greater risk of EPS, while low-potency agents (e.g., Chlorpromazine) cause more antihistaminic (sedation), anti-α-adrenergic (orthostasis), and anticholinergic effects.
š Mnemonic (High Potency): "Highly Try to Fly" ā Haloperidol, Trifluoperazine, Fluphenazine.
Atypical Antipsychotics - Serotonin's Sidekicks
- Dual Action: Primarily block both Dopamine $D_2$ and Serotonin $5HT_{2A}$ receptors.
- Serotonin's Role: $5HT_{2A}$ blockade is key. It ā dopamine release in the nigrostriatal pathway, counteracting the motor side effects of $D_2$ blockade.
- Benefit: This dual action leads to a lower risk of Extrapyramidal Symptoms (EPS) compared to typical antipsychotics.
- Variable Receptor Profiles: Many atypicals also have effects at other receptors, contributing to their side-effect profiles:
- H1-antagonism: ā Sedation, weight gain
- α1-antagonism: ā Orthostatic hypotension

ā Clozapine stands out for its minimal $D_2$ blockade and high affinity for $D_4$ receptors, making it highly effective for treatment-resistant schizophrenia but with a risk of agranulocytosis.
š Mnemonic: For common atypicals: "All Really Quiet Only Zebras Can Pass" (Aripiprazole, Risperidone, Quetiapine, Olanzapine, Ziprasidone, Clozapine, Paliperidone).
Adverse Effect Pathways - Receptor Roulette
-
Dopamine (Dā Receptor) Blockade
- Nigrostriatal Pathway: Leads to Extrapyramidal Symptoms (EPS).
- Acute Dystonia: Sudden, sustained muscle contractions.
- Akathisia: Subjective feeling of restlessness.
- Parkinsonism: Bradykinesia, rigidity, tremor.
- Tardive Dyskinesia (TD): Involuntary, repetitive body movements (chronic use).
- Tuberoinfundibular Pathway: ā Prolactin levels.
- Causes gynecomastia, galactorrhea, and amenorrhea.
- Nigrostriatal Pathway: Leads to Extrapyramidal Symptoms (EPS).
-
Histamine (Hā Receptor) Blockade
- Results in sedation and ā appetite leading to weight gain.
-
Muscarinic (Mā Receptor) Blockade
- Anticholinergic effects: Dry mouth, blurred vision, constipation, urinary retention.
- š Mnemonic: "Dry as a bone, blind as a bat, red as a beet, hot as a hare."
-
Alpha-adrenergic (αā Receptor) Blockade
- Causes orthostatic hypotension and dizziness.
ā Neuroleptic Malignant Syndrome (NMS): A rare but life-threatening emergency from Dā blockade. Key features are Fever, Encephalopathy, Vitals instability, Elevated enzymes (CK), and Rigidity (ālead-pipeā).
HighāYield Points - ā” Biggest Takeaways
- Typical antipsychotics primarily block D2 receptors in the mesolimbic pathway to treat positive symptoms.
- Atypical antipsychotics combine D2 antagonism with serotonin 5-HT2A receptor blockade, which mitigates the risk of Extrapyramidal Symptoms (EPS).
- D2 blockade in the nigrostriatal pathway is responsible for EPS.
- D2 blockade in the tuberoinfundibular pathway causes hyperprolactinemia.
- Newer agents like aripiprazole exhibit D2 partial agonism, stabilizing dopamine output.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING ā FREEor get the app